Sandoz Says An Eli Lilly ADHD Drug Patent Is Invalid
Sandoz Inc. has launched a preemptive strike against Eli Lilly & Co., asking a New Jersey court to declare that an Eli Lilly patent relating to attention-deficit drug Strattera is invalid...To view the full article, register now.
Already a subscriber? Click here to view full article